In Brief: Mass device reclassification
This article was originally published in The Gray Sheet
Mass device reclassification: FDA is developing a concept paper for the mass reclassification of 40-50 preamendments Class III devices that will go through its reengineered regulation development process. The majority of the devices are those for which FDA has called for data under Sec. 515(i) of the device law. FDA plans on issuing a second mass reclassification for the remaining 515(i) devices for which data is due on Feb. 14 and Aug. 14, 1998. The agency also plans to propose reclassification of roughly 10 515(b) devices on an individual basis and a mass call for PMAs for 515(b) devices that have fallen into disuse...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.